Advanced liver disease creates a specific constellation of mobility impairments that are underrecognised because the focus of clinical care is necessarily on the liver itself. But the systemic consequences of cirrhosis -- ascites, hepatic encephalopathy, and sarcopenia -- each have direct effects on balance and gait that make a walking cane clinically relevant well before the disease is terminal.
How Liver Disease Affects Mobility
Ascites and abdominal distension: Significant ascites (fluid accumulation in the peritoneum) shifts the body centre of mass anteriorly and superiorly. The user must lean backward to compensate, which alters gait mechanics, increases lumbar load, and destabilises normal walking patterns. Large-volume ascites can make walking feel top-heavy and unpredictable even without other neurological impairment.
Hepatic encephalopathy: Elevated blood ammonia in cirrhosis affects brain function. In minimal and covert hepatic encephalopathy (grades 0-1), the patient may appear cognitively normal in conversation but show measurable impairment on psychomotor testing -- including slowed reaction time, reduced attention, and impaired spatial processing. All of these affect gait regulation and fall risk, even before overt encephalopathy symptoms appear.
Hepatic sarcopenia: Protein synthesis is impaired in cirrhosis. Muscle wasting in advanced liver disease is among the most severe of any chronic disease -- patients with Child-Pugh C cirrhosis typically have substantial loss of lean body mass affecting lower limb function. The quadriceps and hip flexors (critical for stair climbing and rapid balance recovery) are preferentially affected.
Coagulopathy: Impaired clotting factor synthesis in liver disease means that a minor fall which would cause a bruise in a healthy person can cause serious haematoma or internal bleeding in a patient with cirrhosis. This makes fall prevention disproportionately important -- the consequence of a fall is substantially worse than for the general population.
Child-Pugh Score and Mobility Impact
| Child-Pugh Class | Dominant Mobility Impact | Cane Indication |
|---|---|---|
| A (5-6 points) | Fatigue, some muscle weakness | Extended distances, stairs |
| B (7-9 points) | Moderate ascites, some encephalopathy | Regular daily use |
| C (10-15 points) | Severe sarcopenia, significant ascites, encephalopathy | Essential, every ambulation |
Ascites and Cane Height
Patients with significant ascites change body dimensions as fluid accumulates and drains (post-paracentesis). Cane height should be set for the patient with maximal ascites -- this may need re-evaluation after large-volume paracentesis, as the abdominal protrusion that was compensated for by posture is suddenly reduced, changing the natural standing posture and therefore the optimal cane height.
Cane Selection for Liver Disease Patients
- Coagulopathy consideration: Tip performance is critical. The Steady Tip (3mm lateral slip vs. 14-18mm for standard ferrule on wet surfaces) materially reduces fall probability, which matters more in a patient where falls have severe consequences
- Sarcopenia and grip: Upper limb muscle mass is also reduced in hepatic sarcopenia. The Anatomic Grip (1.9 N/cm2 vs. 4.2 N/cm2 for T-bar) reduces grip fatigue in patients with overall muscle depletion
- Adjustable height: For patients with fluctuating ascites, an adjustable-height shaft allows recalibration as body dimensions change
View the DaiWalk range and use the cane length calculator.
Related reading: Walking Cane for Chronic Kidney Disease | Walking Cane During Cancer Treatment
